POSTMENOPAUSAL OSTEOPOROSIS: A DISTURBANCE IN OSTEOCLASIA*

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-5415|9|12|1078-1085

ISSN： 0002-8614

Source： JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol.9, Iss.12, 1961-12, pp. : 1078-1085

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-term raloxifene for postmenopausal osteoporosis

By Recker Robert R.   Mitlak Bruce H.   Ni Xiao   Krege John H.  

Current Medical Research and Opinion, Vol. 27, Iss. 9, 2011-09 ,pp. : 1755-1761

Informa Healthcare

Access to resources Recommend Favorite

Compliance with drug therapy for postmenopausal osteoporosis

By Weycker D.   Macarios D.   Edelsberg J.   Oster G.  

Osteoporosis International, Vol. 17, Iss. 11, 2006-11 ,pp. : 1645-1652

Springer Publishing Company

Access to resources Recommend Favorite

Risk factors for osteoporosis in postmenopausal African–American women

By Woodson Grattan C.  

Current Medical Research and Opinion, Vol. 20, Iss. 10, 2004-10 ,pp. : 1681-1687

Informa Healthcare

Access to resources Recommend Favorite

Long dosing intervals in the treatment of postmenopausal osteoporosis

By Lewiecki E. Michael  

Current Medical Research and Opinion, Vol. 23, Iss. 11, 2007-11 ,pp. : 2617-2625

Informa Healthcare

Access to resources Recommend Favorite

Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis

By Josse Robert   Khan Aliya   Ngui Daniel   Shapiro Marla  

Current Medical Research and Opinion, Vol. 29, Iss. 3, 2013-03 ,pp. : 205-216

Informa Healthcare

Access to resources Recommend Favorite